A randomized, double blind, placebo controlled, parallel group study to determine the effect of BXL628 in patients with Chronic Non-Bacterial Prostatitis category III Chronic Pelvic Pain Syndrome, CP/CPPS

• Conditions: Chronic Non-Bacterial Prostatitis category III Chronic Pelvic Pain Syndrome, CP/CPPS; MedDRA version: 6.1Level: PTClassification code 10036978

• Registration Number: EUCTR2005-001849-42-IT
• Lead Sponsor: BIOXELL SPA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-12-20
• Last Update Posted: 18 April 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: Male
• Target Recruitment: 120

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: ;Secondary Objective: ;Primary end point(s):